PTC Therapeutics, Inc.
Records under this name other than the patents PTC Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 97 patents it holds.
Back to PTC Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,371,336 | Compounds for Treating Spinal Muscular Atrophy Formerly held In force · High confidence | In force | High confidence | |
| US 10,501,482 | Compounds for Treating Spinal Muscular Atrophy Formerly held In force · High confidence | In force | High confidence | |
| US 9,586,955 | Compounds for Treating Spinal Muscular Atrophy Formerly held In force · High confidence | In force | High confidence | |
| US 9,969,754 | Compounds for Treating Spinal Muscular Atrophy Formerly held In force · High confidence | In force | High confidence | |
| US 12,409,235 | Gene Therapy for Aadc Deficiency Formerly held In force · High confidence | In force | High confidence | |
| US 10,898,585 | Gene Therapy for Aadc Deficiency Formerly held In force · High confidence | In force | High confidence | |
| US 11,865,188 | Gene Therapy for Aadc Deficiency Formerly held In force · High confidence | In force | High confidence | |
| US 12,213,982 | Pharmaceutical compositions comprising sepiapterin and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,023,335 | Method for Treating Pancreatic Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,458,126 | Dhodh Inhibitor for Use in Treating Hematologic Cancers Lapsed on the fee record Ended Oct 4, 2026 · High confidence | Lapsed on the fee record | Ended Oct 4, 2026 | High confidence |